Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01647178
Other study ID # H11-00310
Secondary ID
Status Completed
Phase N/A
First received July 17, 2012
Last updated August 31, 2015
Start date March 2012
Est. completion date October 2013

Study information

Verified date August 2015
Source Kardium Inc.
Contact n/a
Is FDA regulated No
Health authority Canada: Ethics Review Committee
Study type Interventional

Clinical Trial Summary

The proposed trial is to evaluate the use of the TORQ closure assistance device and how it affects pain in the sternum, breathing and quality of life compared to traditional use of needle drivers or similar to close sternal wires.


Recruitment information / eligibility

Status Completed
Enrollment 92
Est. completion date October 2013
Est. primary completion date October 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Referred for elective cardiac surgery at St Paul's Hospital

- Expected to live greater than 12 months

- Capable of giving written informed consent

- Willing to participate in follow-up

- Greater than 18 years of age, and of legal age of consent in host country

Exclusion Criteria:

- Patient has had previous median sternotomy, requiring redo sternotomy

- Surgeon has, prior to enrollment, elected to use alternative closure technique to the interrupted single wire circlage technique (e.g. Figure of 8 technique)

- Surgeon has elected, prior to enrollment. to treat with the TORQ as a prophylactic measure (e.g. in high risk cases where use of the TORQ has been shown to be effective in preventing dehiscence)

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
TORQ assisted sternal closure

Conventional closure


Locations

Country Name City State
Canada St. Paul's Hospital Vancouver British Columbia

Sponsors (2)

Lead Sponsor Collaborator
Kardium Inc. St. Paul's Hospital, Canada

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Respiratory function Pre-op, 2 and 4 days Post-op No
Primary Pain Score Patient reported pain on a scale of 1 to 10 for breathing, coughing and walking 2, 4, 14, 30 and 90 days post op No
See also
  Status Clinical Trial Phase
Withdrawn NCT01463345 - Blood Conservation in Cardiac Surgery N/A
Completed NCT02829203 - Pre-Frailty Risk in Cardiovascular Surgery N/A
Completed NCT01941667 - Transitional Telehealth Home Care: REACH N/A
Completed NCT02569008 - Minimal Volume for Fluid Challenge in Post-operative Patients N/A
Recruiting NCT02146196 - Robotic Assisted Rehabilitation for Heart Failure Patients and Patients After Cardiac Surgery N/A
Completed NCT01662141 - Measure Cardiac Output Using Ultrasound Dilution in Mechanically Ventilated Children N/A
Completed NCT02659982 - Evaluation of EarlySense Home Care Tele-monitoring Device -For Early Detection of Deterioration For Cardiac Patients at Home N/A